Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and Comorbidity Risk
Biological Psychiatry Global Open Science · 2025-07 · 5 (4) · 100517
DOI: 10.1016/j.bpsgos.2025.100517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological Psychiatry Global Open Science, 2025-07. Verfasst von Nicolas P Ciochetti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiological Genomics of Mental Health, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, State of Sao Paulo Research Foundation, National Institute of Mental Health.
Abstract (Originalsprache)
Background
In this study, we investigated the genetic connections between attention-deficit/hyperactivity disorder (ADHD), migraine (MGN), and multisite chronic pain (MCP). The goal was to identify specific shared biological mechanisms that contribute to the overlap between ADHD and these pain-related conditions.
Methods
We utilized various post-genome-wide association study analyses on summary data from samples ranging between 225,534 and 766,345 individuals. In an independent sample of patients with ADHD and control participants (665 cases and 995 controls), we evaluated MGN and MCP polygenic risk scores (PRSs) in relation to comorbid profiles, symptom severity, and neuroimaging brain scores.
Results
The findings show a strong biological overlap between ADHD and MCP, with a less pronounced relationship with MGN. Key regions and genes associated with ADHD and MCP were enriched in neurodevelopmental pathways, including those involved in neuron projection morphogenesis and nervous system development. Drug-set enrichment analysis identified that some of these pathways are potentially influenced by paracetamol, a drug that has been implicated as a class I environmental risk factor for ADHD when exposure occurs prenatally. Causal inference analysis using a 5-fold larger ADHD summary dataset demonstrated stronger effects of MCP on ADHD than the reverse. In the independent sample, higher MCP PRSs were linked to structural brain features, increased comorbidity with substance use and bipolar disorder, and heightened severity of ADHD symptoms.
Conclusions
These findings underscore the significant genetic relationship between ADHD and MCP, suggesting that shared genetic factors may influence brain development and contribute to diverse clinical outcomes in ADHD. In this study, we investigated genetic links between attention-deficit/hyperactivity disorder (ADHD), migraines, and multisite chronic pain (MCP). The results reveal a strong genetic connection between ADHD and MCP, emphasizing shared biological pathways involved in brain development. By analyzing genetic data, researchers found that higher genetic risk for MCP was associated with changes in brain structure, greater ADHD symptom severity, and increased risk of other mental health conditions. These findings suggest that shared genetic factors may play a key role in shaping brain development and influencing diverse clinical outcomes in ADHD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Physiological Genomics of Mental Health, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
- ADHD Outpatient Program & Developmental Psychiatry Program, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Departamento de Psiquiatria, Faculdade de Medicina, Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
- Medical Council, UniEduK and Unifaj, Indaiatuba, Brazil.
- Center for Research and Innovation in Mental Health, National Institute of Developmental Psychiatry, São Paulo, Brazil.
- Center for Teaching and Research in Brain Aging (NUDEC), Federal University of São Paulo, São Paulo, Brazil.
Förderung
- National Council for Scientific and Technological Development
- State of Sao Paulo Research Foundation
- National Institute of Mental Health
Zitieren
APA
Ciochetti, N. P., de Oliveira, V. F., Junger-Santos, I., Bandeira, C. E., Tavares, M. E., Vitola, E. S., Rohde, L. A., de Andrade, G. M., da Silva, B. S., Grevet, E. H., Dotto Bau, C. H., & Rovaris, D. L. (2025). Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and Comorbidity Risk. Biological Psychiatry Global Open Science, 5(4), 100517. https://doi.org/10.1016/j.bpsgos.2025.100517
Vancouver
Ciochetti NP, de Oliveira VF, Junger-Santos I, Bandeira CE, Tavares ME, Vitola ES, et al. Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and Comorbidity Risk. Biological Psychiatry Global Open Science. 2025;5(4):100517. doi:10.1016/j.bpsgos.2025.100517
BibTeX
@article{Ciochetti2025,
author = {Ciochetti, Nicolas P and de Oliveira, Victor F and Junger-Santos, Iago and Bandeira, Cibele E and Tavares, Maria E and Vitola, Eduardo S and Rohde, Luis A and de Andrade, Gustavo Melo and da Silva, Bruna S and Grevet, Eugenio H and Dotto Bau, Claiton H and Rovaris, Diego L},
title = {Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and Comorbidity Risk},
journal = {Biological Psychiatry Global Open Science},
year = {2025},
volume = {5},
number = {4},
pages = {100517},
doi = {10.1016/j.bpsgos.2025.100517}
}
EUVIMED